Scholtz & Company’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-4
Closed -$23K 76
2021
Q1
$23K Buy
+4
New +$23K 0.01% 68